Skip to main content
. 2025 Sep 1;14(9):882. doi: 10.3390/antibiotics14090882
AIDS Acquired immunodeficiency syndrome
AMR Antimicrobial resistance
BLBLI Beta-lactam–beta-lactamase inhibitor
BSI Bloodstream infection
CCI Charlson comorbidity index
CI Confidence interval
CLSI Clinical and Laboratory Standards Institute
COPD Chronic obstructive pulmonary disease
CRP C-reactive protein
CVC Central venous catheter
E. coli Escherichia coli
EPV Events per variable
ESBL Extended-spectrum beta-lactamase
HIV Human immunodeficiency virus
ICU Intensive care unit
IIAT Inappropriate initial antibiotic therapy
IQR Interquartile range
LOS Length of stay
MDRO Multidrug-resistant organism
OR Odds ratio
PBS Pitt bacteremia score
qSOFA Quick sequential organ failure assessment
SOFA Sequential organ failure assessment
SPSS Statistical product and service solutions
UPEC Uropathogenic Escherichia coli
UTI Urinary tract infection
VIF Variance inflation factors
WHO World Health Organization